Description

4-((5,6,7,8-Tetrahydroimidazo[1,2-A]Pyrazin-2-Yl)Methyl)Morpholine is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure, designed for critical synthesis pathways. Its core value lies in enabling the development of novel, potent therapeutic agents, particularly in oncology and central nervous system (CNS) research. This compound is essential for medicinal chemists and process development scientists in pharmaceutical R&D and fine chemical manufacturing who require reliable, high-quality building blocks for drug discovery and development.

Application

This specialized intermediate serves as a key scaffold in the synthesis of bioactive molecules. Its primary applications include:

• Pharmaceutical Intermediate: A critical building block in the synthesis of novel drug candidates, particularly kinase inhibitors and other targeted therapies.
• Medicinal Chemistry Research: Used in lead optimization and structure-activity relationship (SAR) studies to develop new chemical entities.
• Oncology Drug Development: Incorporated into the core structure of compounds being investigated for anti-cancer properties.
• CNS-Active Compound Synthesis: Serves as a precursor for molecules targeting neurological disorders.
• Process Chemistry & Scale-Up: Used in the development and optimization of commercial-scale manufacturing routes for active pharmaceutical ingredients (APIs).
• Contract Research & Manufacturing (CRO/CMO): Supplied to organizations specializing in custom synthesis and development services.

Basic Information

Product Name	4-((5,6,7,8-Tetrahydroimidazo[1,2-A]Pyrazin-2-Yl)Methyl)Morpholine
CAS No.	1422063-82-8
Molecular Formula	C11H18N4O
Molecular Weight	222.29 g/mol
Synonyms	4-[(5,6,7,8-Tetrahydroimidazo[1,2-a]pyrazin-2-yl)methyl]morpholine; Morpholine, 4-[(5,6,7,8-tetrahydroimidazo[1,2-a]pyrazin-2-yl)methyl]-; 1422063-82-8; 4-((5,6,7,8-tetrahydroimidazo[1,2-a]pyrazin-2-yl)methyl)morpholine; UNII-9R1I8H6F7C; 9R1I8H6F7C; CHEMBL3186660; DTXSID60644669
EINECS	Contact for details

Quality Control

Our 4-((5,6,7,8-Tetrahydroimidazo[1,2-A]Pyrazin-2-Yl)Methyl)Morpholine is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC, NMR, and MS, to ensure identity, purity, and consistency. We provide comprehensive Certificates of Analysis (COA) with each shipment, detailing all critical quality attributes. Our production adheres to cGMP guidelines where applicable, ensuring suitability for use in regulated pharmaceutical development.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, well-ventilated place at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed under an inert atmosphere (e.g., nitrogen or argon) after opening to prevent degradation. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (HPLC)	Conforms
Identification (NMR)	Conforms
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.